Veterinary Auto-Immune Therapeutics Market
Analysis of Veterinary Auto-immune Therapeutics Market by Corticosteroids, Azathioprine, Cyclosporine, Mycophenolate, Leflunomide, Cyclophosphamide, Levothyroxine, Folic Acid, Hydrochloroquine, and Chloroquine Therapy Types
Evolving Veterinary Care and Disease Management to Aid Veterinary Auto-immune Therapeutics Market, Read FMI's Latest Report for Detailed Growth Insights from 30+ Nations
Veterinary Auto-immune Therapeutics Market Outlook (2023 to 2033)
The global veterinary auto-immune therapeutics market is projected to be appraised at US$ 71,720.6 million by 2033, up from US$ 42,815.7 million in 2023, advancing at a CAGR of 5.3% from 2023 to 2033.
The adoption of veterinary auto-immune therapeutics is on the surge as several new ways of treating autoimmune diseases in animals using various drugs and other therapies like surgeries and stem cell therapies are evolving worldwide.
The demand for these drugs also rises as used to reduce the symptoms associated with the specific autoimmune disease. Furthermore, auto-immune disease treatment is gaining more attention owing to an increased threat of zoonotic disease transfer among humans, in turn, positively impacting the veterinary auto-immune therapeutics market outlook.
Hence, the growing incidence of zoonotic disease transfer is changing business operations of the animal healthcare industry as emergency care.
| Attributes | Details |
|---|---|
| Veterinary Auto-immune Therapeutics Market Share (2022) | US$ 41,087.7 million |
| Veterinary Auto-immune Therapeutics Market Share (2023) | US$ 42,815.7 million |
| Veterinary Auto-immune Therapeutics Market Share (2033) | US$ 71,720.6 million |
| Veterinary Auto-immune Therapeutics Market Share (2023 to 2033) | 5.3% |
The veterinary auto-immune therapeutics market growth is fuelled by veterinary hospitals as they are offering a wide range of therapeutic services for companion animals. An increase in the prevalence of autoimmune illness and a rise in Research and Development efforts to provide the best possible treatments in tandem with a surge in the use of therapeutics for the condition are also anticipated to contribute to the market growth in coming years.
Moreover, the market is expanded by the rise in autoimmune disease incidence and early illness detection, and the recent introduction of cutting-edge therapies during the forecast period. A significant number of late-stage pipeline medications are also present, including tocilizumab, certolizumab, baricitinib, etanercept, secukinumab, elotuzumab, abatacept, PF-06438179, apremilast, golimumab, certolizumab, ustekinumab, tofacitinib, and others.
The increasing transfer of zoonotic diseases among immunosuppressed patients is a prime factor responsible for the rising awareness of the auto-immune disease among companion animals.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
What are the Key Veterinary Auto-Immune Therapeutics Market?
The high threat of HIV transfer from the animal source to a person with suppressed immunity, and the transfer of allergic components from companion animals to family members are also spiking the demand for veterinary auto-immune therapeutics.
The growing incidence of autoimmune diseases in livestock animals has decreased the quality of meat consumed especially in pharmaceutical manufacturing. Moreover, the focus on livestock health among African countries which are the main exporters of livestock is further surging the demand for autoimmune disease therapy.
However, limited therapy options for animals in developing countries and a lack of awareness are hindering the growth of the veterinary auto-immune therapeutics market.
Why is North America Likely to Lead the Veterinary Auto-Immune Therapeutics Market?
Due to numerous government-sponsored programs that promote these diagnostic tests, North America held the largest market share in the world for the diagnosis of animal auto-immune diseases accounting for 37.2% in 2022. The increased demand for all healthcare improvements for animal welfare is a result of the region's increased meat consumption.
There is a huge knowledge of the effects and impacts of auto-immune disorders thanks to their prevalence, in turn expanding the veterinary auto-immune therapeutics market size.
Sabyasachi Ghosh
Principal Consultant
Talk to Analyst
Find your sweet spots for generating winning opportunities in this market.
What is the Growth Outlook for the Europe Veterinary Auto-Immune Therapeutics Market?
Europe held 26.5% of the veterinary auto-immune therapeutics market share in 2022. The main factor driving rising utilization rates is the increased awareness of animal autoimmune diseases brought on by programs in research, support, advocacy, and education.
The European Commission is pursuing a number of initiatives to raise public knowledge of the factors that may contribute to the onset of animal auto-immune diseases, thereby spurring the adoption of such therapeutics.
How is the Start-up Ecosystem in the Veterinary Auto-Immune Therapeutics Market?
A Med City biotech company received more than US$330,000 in federal money to explore gene therapy for dogs and possibly people in the future. The National Institutes of Health has given a US$337,443 Phase I Small Business Innovation Research grant to Life Engine Animal Health, or LEAH Labs, led by CEO and co-founder Dr. Wes Wierson.
With assistance from the Mayo Clinic, Wierson developed gene editing methods that are used by LEAH Labs. The Mayo Clinic granted a license to LEAH Labs for the study. Downtown Rochester is where LEAH Labs is headquartered.
In the second quarter of 2022, pilot tests for the start-up's first product, a CAR-T cell therapy for cancerous dogs, are anticipated to begin. The objective is to develop a treatment for canine B cell lymphoma malignancy. An estimated 300,000 canines every year succumb to that form of cancer, which is analogous to Non-lymphoma Hodgkin's in people.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
What is the Competition Landscape in the Veterinary Auto-Immune Therapeutics Market?
Market players are employing various organic and inorganic strategies including mergers & acquisitions, partnerships, collaborations, etc. in order to consolidate their position in the veterinary auto-immune therapeutics market.
A few of the recent developments in the veterinary auto-immune therapeutics market are:
- A company called Luvig Pharmaceuticals, Inc. announced its establishment in May 2022 with the goal of creating innovative pharmaceuticals that cure autoimmune illnesses without impairing healthy immune function and promote systems of immunological homeostasis. The business has completed a US$ 47 million Series A funding to support this goal, which was headed by Novo Holdings A/S and Platanus and included Bristol-Myers Squibb, Digitalis Ventures, and Mission BioCapital.
- Leading provider of life science solutions QIAGEN N.V. was purchased by Thermo Fisher Scientific Inc. They operate in 25 nations and offer diagnostic solutions for all geographical areas.
- A unique blood test that displays the risk index of autoimmune illnesses was introduced by Progentec. In 12 weeks, it can evaluate the propensity for systemic lupus erythematosus.
Key Players in the Global Market
- Aratana Therapeutics Inc.
- Pfizer Inc.
- Vet-Stem Inc.
- Ambrx Inc.
- Taconic Biosciences Inc.
- JBS United
- Virbac
- Eli Lily and Company
- Jaguar Animal Health Inc.
Scope of the Report
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | US$ Million for Value |
| Key Regions Covered |
|
| Key Countries Covered |
|
| Key Segments Covered |
|
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, Trend Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
Veterinary Auto-immune Therapeutics Market Segmentation
By Therapy Type:
- Corticosteroids
- Azathioprine
- Cyclosporine
- Mycophenolate
- Leflunomide
- Cyclophosphamide
- Levothyroxine
- Folic Acid
- Hydrochloroquine
- Chloroquine
By Disease Indication:
- Hypothyroidism
- Pemphigus Disease
- Canine Lupus
- Auto-immune Hemolytic Anemia
- Bollous Pemphigoid
- Discoid Lupus Erythematosus (DLE)
- Immune-related Arthritis
- Others
By Animal Type:
- Companion Animal
- Dogs
- Cats
- Horse
- Swine
- Cattle
- Live Stock Animal
- Poultry
- Fish
- Sheep
By Distribution Channel:
- Veterinary Hospitals
- Veterinary Clinics
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa (MEA)
Frequently Asked Questions
What is the Current Veterinary Auto-Immune Therapeutics Market Valuation?
The market is estimated to secure a valuation of US$ 42,815.7 million in 2023.
What is the Market CAGR Rate from 2023 to 2033?
The market is estimated to expand at a CAGR of 5.3% between 2023 and 2033.
What are the Top 3 Market Players?
The top 3 market players are Aratana Therapeutics Inc., Pfizer Inc., and Vet-Stem Inc.
What was North America’s Revenue in 2022?
North America generated 37.2% revenue in 2022.
What is the Predicted Market Size in 2033?
The market is likely to be valued at US$ 71,720.6 million in 2033.
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Therapy Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Therapy Type, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Therapy Type, 2023 to 2033 5.3.1. Corticosteroids, Azathioprine 5.3.2. Cyclosporine 5.3.3. Mycophenolate 5.3.4. Leflunomide 5.3.5. Cyclophosphamide 5.3.6. Levothyroxine 5.3.7. Folic Acid 5.3.8. Hydroxychloroquine 5.3.9. Chloroquine 5.4. Y-o-Y Growth Trend Analysis By Therapy Type, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Therapy Type, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Disease Indication 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Disease Indication, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Disease Indication, 2023 to 2033 6.3.1. Hypothyroidism 6.3.2. Pemphigus Disease 6.3.3. Canine Lupus 6.3.4. Auto-Immune Hemolytic Anemia 6.3.5. Bullous Pemphigoid 6.3.6. Discoid Lupus Erythematosus (DLE) 6.3.7. Immune-related arthritis 6.3.8. Others 6.4. Y-o-Y Growth Trend Analysis By Disease Indication, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Disease Indication, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Animal Type 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By Animal Type, 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Animal Type, 2023 to 2033 7.3.1. Companion Animal 7.3.2. Dogs 7.3.3. Cats 7.3.4. Horse 7.3.5. Live Stock Animal 7.3.6. Cattle 7.3.7. Swine 7.3.8. Poultry 7.3.9. Fish 7.3.10. Sheep 7.4. Y-o-Y Growth Trend Analysis By Animal Type, 2018 to 2022 7.5. Absolute $ Opportunity Analysis By Animal Type, 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Million) Analysis By Distribution Channel, 2018 to 2022 8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Distribution Channel, 2023 to 2033 8.3.1. Veterinary Hospitals 8.3.2. Veterinary Clinics 8.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2018 to 2022 8.5. Absolute $ Opportunity Analysis By Distribution Channel, 2023 to 2033 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 9.1. Introduction 9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 9.3.1. North America 9.3.2. Latin America 9.3.3. Western Europe 9.3.4. Eastern Europe 9.3.5. South Asia and Pacific 9.3.6. East Asia 9.3.7. Middle East and Africa 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. USA 10.2.1.2. Canada 10.2.2. By Therapy Type 10.2.3. By Disease Indication 10.2.4. By Animal Type 10.2.5. By Distribution Channel 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Therapy Type 10.3.3. By Disease Indication 10.3.4. By Animal Type 10.3.5. By Distribution Channel 10.4. Key Takeaways 11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Brazil 11.2.1.2. Mexico 11.2.1.3. Rest of Latin America 11.2.2. By Therapy Type 11.2.3. By Disease Indication 11.2.4. By Animal Type 11.2.5. By Distribution Channel 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Therapy Type 11.3.3. By Disease Indication 11.3.4. By Animal Type 11.3.5. By Distribution Channel 11.4. Key Takeaways 12. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. Germany 12.2.1.2. UK 12.2.1.3. France 12.2.1.4. Spain 12.2.1.5. Italy 12.2.1.6. Rest of Western Europe 12.2.2. By Therapy Type 12.2.3. By Disease Indication 12.2.4. By Animal Type 12.2.5. By Distribution Channel 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Therapy Type 12.3.3. By Disease Indication 12.3.4. By Animal Type 12.3.5. By Distribution Channel 12.4. Key Takeaways 13. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. Poland 13.2.1.2. Russia 13.2.1.3. Czech Republic 13.2.1.4. Romania 13.2.1.5. Rest of Eastern Europe 13.2.2. By Therapy Type 13.2.3. By Disease Indication 13.2.4. By Animal Type 13.2.5. By Distribution Channel 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Therapy Type 13.3.3. By Disease Indication 13.3.4. By Animal Type 13.3.5. By Distribution Channel 13.4. Key Takeaways 14. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. India 14.2.1.2. Bangladesh 14.2.1.3. Australia 14.2.1.4. New Zealand 14.2.1.5. Rest of South Asia and Pacific 14.2.2. By Therapy Type 14.2.3. By Disease Indication 14.2.4. By Animal Type 14.2.5. By Distribution Channel 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Therapy Type 14.3.3. By Disease Indication 14.3.4. By Animal Type 14.3.5. By Distribution Channel 14.4. Key Takeaways 15. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. China 15.2.1.2. Japan 15.2.1.3. South Korea 15.2.2. By Therapy Type 15.2.3. By Disease Indication 15.2.4. By Animal Type 15.2.5. By Distribution Channel 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Therapy Type 15.3.3. By Disease Indication 15.3.4. By Animal Type 15.3.5. By Distribution Channel 15.4. Key Takeaways 16. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 16.2.1. By Country 16.2.1.1. GCC Countries 16.2.1.2. South Africa 16.2.1.3. Israel 16.2.1.4. Rest of MEA 16.2.2. By Therapy Type 16.2.3. By Disease Indication 16.2.4. By Animal Type 16.2.5. By Distribution Channel 16.3. Market Attractiveness Analysis 16.3.1. By Country 16.3.2. By Therapy Type 16.3.3. By Disease Indication 16.3.4. By Animal Type 16.3.5. By Distribution Channel 16.4. Key Takeaways 17. Key Countries Market Analysis 17.1. USA 17.1.1. Pricing Analysis 17.1.2. Market Share Analysis, 2022 17.1.2.1. By Therapy Type 17.1.2.2. By Disease Indication 17.1.2.3. By Animal Type 17.1.2.4. By Distribution Channel 17.2. Canada 17.2.1. Pricing Analysis 17.2.2. Market Share Analysis, 2022 17.2.2.1. By Therapy Type 17.2.2.2. By Disease Indication 17.2.2.3. By Animal Type 17.2.2.4. By Distribution Channel 17.3. Brazil 17.3.1. Pricing Analysis 17.3.2. Market Share Analysis, 2022 17.3.2.1. By Therapy Type 17.3.2.2. By Disease Indication 17.3.2.3. By Animal Type 17.3.2.4. By Distribution Channel 17.4. Mexico 17.4.1. Pricing Analysis 17.4.2. Market Share Analysis, 2022 17.4.2.1. By Therapy Type 17.4.2.2. By Disease Indication 17.4.2.3. By Animal Type 17.4.2.4. By Distribution Channel 17.5. Germany 17.5.1. Pricing Analysis 17.5.2. Market Share Analysis, 2022 17.5.2.1. By Therapy Type 17.5.2.2. By Disease Indication 17.5.2.3. By Animal Type 17.5.2.4. By Distribution Channel 17.6. UK 17.6.1. Pricing Analysis 17.6.2. Market Share Analysis, 2022 17.6.2.1. By Therapy Type 17.6.2.2. By Disease Indication 17.6.2.3. By Animal Type 17.6.2.4. By Distribution Channel 17.7. France 17.7.1. Pricing Analysis 17.7.2. Market Share Analysis, 2022 17.7.2.1. By Therapy Type 17.7.2.2. By Disease Indication 17.7.2.3. By Animal Type 17.7.2.4. By Distribution Channel 17.8. Spain 17.8.1. Pricing Analysis 17.8.2. Market Share Analysis, 2022 17.8.2.1. By Therapy Type 17.8.2.2. By Disease Indication 17.8.2.3. By Animal Type 17.8.2.4. By Distribution Channel 17.9. Italy 17.9.1. Pricing Analysis 17.9.2. Market Share Analysis, 2022 17.9.2.1. By Therapy Type 17.9.2.2. By Disease Indication 17.9.2.3. By Animal Type 17.9.2.4. By Distribution Channel 17.10. Poland 17.10.1. Pricing Analysis 17.10.2. Market Share Analysis, 2022 17.10.2.1. By Therapy Type 17.10.2.2. By Disease Indication 17.10.2.3. By Animal Type 17.10.2.4. By Distribution Channel 17.11. Russia 17.11.1. Pricing Analysis 17.11.2. Market Share Analysis, 2022 17.11.2.1. By Therapy Type 17.11.2.2. By Disease Indication 17.11.2.3. By Animal Type 17.11.2.4. By Distribution Channel 17.12. Czech Republic 17.12.1. Pricing Analysis 17.12.2. Market Share Analysis, 2022 17.12.2.1. By Therapy Type 17.12.2.2. By Disease Indication 17.12.2.3. By Animal Type 17.12.2.4. By Distribution Channel 17.13. Romania 17.13.1. Pricing Analysis 17.13.2. Market Share Analysis, 2022 17.13.2.1. By Therapy Type 17.13.2.2. By Disease Indication 17.13.2.3. By Animal Type 17.13.2.4. By Distribution Channel 17.14. India 17.14.1. Pricing Analysis 17.14.2. Market Share Analysis, 2022 17.14.2.1. By Therapy Type 17.14.2.2. By Disease Indication 17.14.2.3. By Animal Type 17.14.2.4. By Distribution Channel 17.15. Bangladesh 17.15.1. Pricing Analysis 17.15.2. Market Share Analysis, 2022 17.15.2.1. By Therapy Type 17.15.2.2. By Disease Indication 17.15.2.3. By Animal Type 17.15.2.4. By Distribution Channel 17.16. Australia 17.16.1. Pricing Analysis 17.16.2. Market Share Analysis, 2022 17.16.2.1. By Therapy Type 17.16.2.2. By Disease Indication 17.16.2.3. By Animal Type 17.16.2.4. By Distribution Channel 17.17. New Zealand 17.17.1. Pricing Analysis 17.17.2. Market Share Analysis, 2022 17.17.2.1. By Therapy Type 17.17.2.2. By Disease Indication 17.17.2.3. By Animal Type 17.17.2.4. By Distribution Channel 17.18. China 17.18.1. Pricing Analysis 17.18.2. Market Share Analysis, 2022 17.18.2.1. By Therapy Type 17.18.2.2. By Disease Indication 17.18.2.3. By Animal Type 17.18.2.4. By Distribution Channel 17.19. Japan 17.19.1. Pricing Analysis 17.19.2. Market Share Analysis, 2022 17.19.2.1. By Therapy Type 17.19.2.2. By Disease Indication 17.19.2.3. By Animal Type 17.19.2.4. By Distribution Channel 17.20. South Korea 17.20.1. Pricing Analysis 17.20.2. Market Share Analysis, 2022 17.20.2.1. By Therapy Type 17.20.2.2. By Disease Indication 17.20.2.3. By Animal Type 17.20.2.4. By Distribution Channel 17.21. GCC Countries 17.21.1. Pricing Analysis 17.21.2. Market Share Analysis, 2022 17.21.2.1. By Therapy Type 17.21.2.2. By Disease Indication 17.21.2.3. By Animal Type 17.21.2.4. By Distribution Channel 17.22. South Africa 17.22.1. Pricing Analysis 17.22.2. Market Share Analysis, 2022 17.22.2.1. By Therapy Type 17.22.2.2. By Disease Indication 17.22.2.3. By Animal Type 17.22.2.4. By Distribution Channel 17.23. Israel 17.23.1. Pricing Analysis 17.23.2. Market Share Analysis, 2022 17.23.2.1. By Therapy Type 17.23.2.2. By Disease Indication 17.23.2.3. By Animal Type 17.23.2.4. By Distribution Channel 18. Market Structure Analysis 18.1. Competition Dashboard 18.2. Competition Benchmarking 18.3. Market Share Analysis of Top Players 18.3.1. By Regional 18.3.2. By Therapy Type 18.3.3. By Disease Indication 18.3.4. By Animal Type 18.3.5. By Distribution Channel 19. Competition Analysis 19.1. Competition Deep Dive 19.1.1. Aratana Therapeutics Inc. 19.1.1.1. Overview 19.1.1.2. Product Portfolio 19.1.1.3. Profitability by Market Segments 19.1.1.4. Sales Footprint 19.1.1.5. Strategy Overview 19.1.1.5.1. Marketing Strategy 19.1.2. Pfizer Inc. 19.1.2.1. Overview 19.1.2.2. Product Portfolio 19.1.2.3. Profitability by Market Segments 19.1.2.4. Sales Footprint 19.1.2.5. Strategy Overview 19.1.2.5.1. Marketing Strategy 19.1.3. Vet-Stem, Inc. 19.1.3.1. Overview 19.1.3.2. Product Portfolio 19.1.3.3. Profitability by Market Segments 19.1.3.4. Sales Footprint 19.1.3.5. Strategy Overview 19.1.3.5.1. Marketing Strategy 19.1.4. Ambrx Inc. 19.1.4.1. Overview 19.1.4.2. Product Portfolio 19.1.4.3. Profitability by Market Segments 19.1.4.4. Sales Footprint 19.1.4.5. Strategy Overview 19.1.4.5.1. Marketing Strategy 19.1.5. Taconic Biosciences, Inc. 19.1.5.1. Overview 19.1.5.2. Product Portfolio 19.1.5.3. Profitability by Market Segments 19.1.5.4. Sales Footprint 19.1.5.5. Strategy Overview 19.1.5.5.1. Marketing Strategy 19.1.6. JBS Value (US$ Million)ed 19.1.6.1. Overview 19.1.6.2. Product Portfolio 19.1.6.3. Profitability by Market Segments 19.1.6.4. Sales Footprint 19.1.6.5. Strategy Overview 19.1.6.5.1. Marketing Strategy 19.1.7. Virbac 19.1.7.1. Overview 19.1.7.2. Product Portfolio 19.1.7.3. Profitability by Market Segments 19.1.7.4. Sales Footprint 19.1.7.5. Strategy Overview 19.1.7.5.1. Marketing Strategy 19.1.8. Eli Lilly and Company 19.1.8.1. Overview 19.1.8.2. Product Portfolio 19.1.8.3. Profitability by Market Segments 19.1.8.4. Sales Footprint 19.1.8.5. Strategy Overview 19.1.8.5.1. Marketing Strategy 19.1.9. Jaguar Animal Health Inc. 19.1.9.1. Overview 19.1.9.2. Product Portfolio 19.1.9.3. Profitability by Market Segments 19.1.9.4. Sales Footprint 19.1.9.5. Strategy Overview 19.1.9.5.1. Marketing Strategy 19.1.10. Novartis AG 19.1.10.1. Overview 19.1.10.2. Product Portfolio 19.1.10.3. Profitability by Market Segments 19.1.10.4. Sales Footprint 19.1.10.5. Strategy Overview 19.1.10.5.1. Marketing Strategy 20. Assumptions & Acronyms Used 21. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033 Table 2: Global Market Value (US$ Million) Forecast by Therapy Type, 2018 to 2033 Table 3: Global Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033 Table 4: Global Market Value (US$ Million) Forecast by Animal Type, 2018 to 2033 Table 5: Global Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033 Table 6: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 7: North America Market Value (US$ Million) Forecast by Therapy Type, 2018 to 2033 Table 8: North America Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033 Table 9: North America Market Value (US$ Million) Forecast by Animal Type, 2018 to 2033 Table 10: North America Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033 Table 11: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 12: Latin America Market Value (US$ Million) Forecast by Therapy Type, 2018 to 2033 Table 13: Latin America Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033 Table 14: Latin America Market Value (US$ Million) Forecast by Animal Type, 2018 to 2033 Table 15: Latin America Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033 Table 16: Western Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 17: Western Europe Market Value (US$ Million) Forecast by Therapy Type, 2018 to 2033 Table 18: Western Europe Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033 Table 19: Western Europe Market Value (US$ Million) Forecast by Animal Type, 2018 to 2033 Table 20: Western Europe Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033 Table 21: Eastern Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 22: Eastern Europe Market Value (US$ Million) Forecast by Therapy Type, 2018 to 2033 Table 23: Eastern Europe Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033 Table 24: Eastern Europe Market Value (US$ Million) Forecast by Animal Type, 2018 to 2033 Table 25: Eastern Europe Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033 Table 26: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 27: South Asia and Pacific Market Value (US$ Million) Forecast by Therapy Type, 2018 to 2033 Table 28: South Asia and Pacific Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033 Table 29: South Asia and Pacific Market Value (US$ Million) Forecast by Animal Type, 2018 to 2033 Table 30: South Asia and Pacific Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033 Table 31: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 32: East Asia Market Value (US$ Million) Forecast by Therapy Type, 2018 to 2033 Table 33: East Asia Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033 Table 34: East Asia Market Value (US$ Million) Forecast by Animal Type, 2018 to 2033 Table 35: East Asia Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033 Table 36: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 37: Middle East and Africa Market Value (US$ Million) Forecast by Therapy Type, 2018 to 2033 Table 38: Middle East and Africa Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033 Table 39: Middle East and Africa Market Value (US$ Million) Forecast by Animal Type, 2018 to 2033 Table 40: Middle East and Africa Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033
Sabyasachi Ghosh
Principal Consultant
Talk to Analyst
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Market Value (US$ Million) by Therapy Type, 2023 to 2033 Figure 2: Global Market Value (US$ Million) by Disease Indication, 2023 to 2033 Figure 3: Global Market Value (US$ Million) by Animal Type, 2023 to 2033 Figure 4: Global Market Value (US$ Million) by Distribution Channel, 2023 to 2033 Figure 5: Global Market Value (US$ Million) by Region, 2023 to 2033 Figure 6: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033 Figure 7: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033 Figure 8: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033 Figure 9: Global Market Value (US$ Million) Analysis by Therapy Type, 2018 to 2033 Figure 10: Global Market Value Share (%) and BPS Analysis by Therapy Type, 2023 to 2033 Figure 11: Global Market Y-o-Y Growth (%) Projections by Therapy Type, 2023 to 2033 Figure 12: Global Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033 Figure 13: Global Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033 Figure 14: Global Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033 Figure 15: Global Market Value (US$ Million) Analysis by Animal Type, 2018 to 2033 Figure 16: Global Market Value Share (%) and BPS Analysis by Animal Type, 2023 to 2033 Figure 17: Global Market Y-o-Y Growth (%) Projections by Animal Type, 2023 to 2033 Figure 18: Global Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033 Figure 19: Global Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033 Figure 20: Global Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033 Figure 21: Global Market Attractiveness by Therapy Type, 2023 to 2033 Figure 22: Global Market Attractiveness by Disease Indication, 2023 to 2033 Figure 23: Global Market Attractiveness by Animal Type, 2023 to 2033 Figure 24: Global Market Attractiveness by Distribution Channel, 2023 to 2033 Figure 25: Global Market Attractiveness by Region, 2023 to 2033 Figure 26: North America Market Value (US$ Million) by Therapy Type, 2023 to 2033 Figure 27: North America Market Value (US$ Million) by Disease Indication, 2023 to 2033 Figure 28: North America Market Value (US$ Million) by Animal Type, 2023 to 2033 Figure 29: North America Market Value (US$ Million) by Distribution Channel, 2023 to 2033 Figure 30: North America Market Value (US$ Million) by Country, 2023 to 2033 Figure 31: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 32: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 33: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 34: North America Market Value (US$ Million) Analysis by Therapy Type, 2018 to 2033 Figure 35: North America Market Value Share (%) and BPS Analysis by Therapy Type, 2023 to 2033 Figure 36: North America Market Y-o-Y Growth (%) Projections by Therapy Type, 2023 to 2033 Figure 37: North America Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033 Figure 38: North America Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033 Figure 39: North America Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033 Figure 40: North America Market Value (US$ Million) Analysis by Animal Type, 2018 to 2033 Figure 41: North America Market Value Share (%) and BPS Analysis by Animal Type, 2023 to 2033 Figure 42: North America Market Y-o-Y Growth (%) Projections by Animal Type, 2023 to 2033 Figure 43: North America Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033 Figure 44: North America Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033 Figure 45: North America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033 Figure 46: North America Market Attractiveness by Therapy Type, 2023 to 2033 Figure 47: North America Market Attractiveness by Disease Indication, 2023 to 2033 Figure 48: North America Market Attractiveness by Animal Type, 2023 to 2033 Figure 49: North America Market Attractiveness by Distribution Channel, 2023 to 2033 Figure 50: North America Market Attractiveness by Country, 2023 to 2033 Figure 51: Latin America Market Value (US$ Million) by Therapy Type, 2023 to 2033 Figure 52: Latin America Market Value (US$ Million) by Disease Indication, 2023 to 2033 Figure 53: Latin America Market Value (US$ Million) by Animal Type, 2023 to 2033 Figure 54: Latin America Market Value (US$ Million) by Distribution Channel, 2023 to 2033 Figure 55: Latin America Market Value (US$ Million) by Country, 2023 to 2033 Figure 56: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 57: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 58: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 59: Latin America Market Value (US$ Million) Analysis by Therapy Type, 2018 to 2033 Figure 60: Latin America Market Value Share (%) and BPS Analysis by Therapy Type, 2023 to 2033 Figure 61: Latin America Market Y-o-Y Growth (%) Projections by Therapy Type, 2023 to 2033 Figure 62: Latin America Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033 Figure 63: Latin America Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033 Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033 Figure 65: Latin America Market Value (US$ Million) Analysis by Animal Type, 2018 to 2033 Figure 66: Latin America Market Value Share (%) and BPS Analysis by Animal Type, 2023 to 2033 Figure 67: Latin America Market Y-o-Y Growth (%) Projections by Animal Type, 2023 to 2033 Figure 68: Latin America Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033 Figure 69: Latin America Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033 Figure 70: Latin America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033 Figure 71: Latin America Market Attractiveness by Therapy Type, 2023 to 2033 Figure 72: Latin America Market Attractiveness by Disease Indication, 2023 to 2033 Figure 73: Latin America Market Attractiveness by Animal Type, 2023 to 2033 Figure 74: Latin America Market Attractiveness by Distribution Channel, 2023 to 2033 Figure 75: Latin America Market Attractiveness by Country, 2023 to 2033 Figure 76: Western Europe Market Value (US$ Million) by Therapy Type, 2023 to 2033 Figure 77: Western Europe Market Value (US$ Million) by Disease Indication, 2023 to 2033 Figure 78: Western Europe Market Value (US$ Million) by Animal Type, 2023 to 2033 Figure 79: Western Europe Market Value (US$ Million) by Distribution Channel, 2023 to 2033 Figure 80: Western Europe Market Value (US$ Million) by Country, 2023 to 2033 Figure 81: Western Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 82: Western Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 83: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 84: Western Europe Market Value (US$ Million) Analysis by Therapy Type, 2018 to 2033 Figure 85: Western Europe Market Value Share (%) and BPS Analysis by Therapy Type, 2023 to 2033 Figure 86: Western Europe Market Y-o-Y Growth (%) Projections by Therapy Type, 2023 to 2033 Figure 87: Western Europe Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033 Figure 88: Western Europe Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033 Figure 89: Western Europe Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033 Figure 90: Western Europe Market Value (US$ Million) Analysis by Animal Type, 2018 to 2033 Figure 91: Western Europe Market Value Share (%) and BPS Analysis by Animal Type, 2023 to 2033 Figure 92: Western Europe Market Y-o-Y Growth (%) Projections by Animal Type, 2023 to 2033 Figure 93: Western Europe Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033 Figure 94: Western Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033 Figure 95: Western Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033 Figure 96: Western Europe Market Attractiveness by Therapy Type, 2023 to 2033 Figure 97: Western Europe Market Attractiveness by Disease Indication, 2023 to 2033 Figure 98: Western Europe Market Attractiveness by Animal Type, 2023 to 2033 Figure 99: Western Europe Market Attractiveness by Distribution Channel, 2023 to 2033 Figure 100: Western Europe Market Attractiveness by Country, 2023 to 2033 Figure 101: Eastern Europe Market Value (US$ Million) by Therapy Type, 2023 to 2033 Figure 102: Eastern Europe Market Value (US$ Million) by Disease Indication, 2023 to 2033 Figure 103: Eastern Europe Market Value (US$ Million) by Animal Type, 2023 to 2033 Figure 104: Eastern Europe Market Value (US$ Million) by Distribution Channel, 2023 to 2033 Figure 105: Eastern Europe Market Value (US$ Million) by Country, 2023 to 2033 Figure 106: Eastern Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 107: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 108: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 109: Eastern Europe Market Value (US$ Million) Analysis by Therapy Type, 2018 to 2033 Figure 110: Eastern Europe Market Value Share (%) and BPS Analysis by Therapy Type, 2023 to 2033 Figure 111: Eastern Europe Market Y-o-Y Growth (%) Projections by Therapy Type, 2023 to 2033 Figure 112: Eastern Europe Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033 Figure 113: Eastern Europe Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033 Figure 114: Eastern Europe Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033 Figure 115: Eastern Europe Market Value (US$ Million) Analysis by Animal Type, 2018 to 2033 Figure 116: Eastern Europe Market Value Share (%) and BPS Analysis by Animal Type, 2023 to 2033 Figure 117: Eastern Europe Market Y-o-Y Growth (%) Projections by Animal Type, 2023 to 2033 Figure 118: Eastern Europe Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033 Figure 119: Eastern Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033 Figure 120: Eastern Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033 Figure 121: Eastern Europe Market Attractiveness by Therapy Type, 2023 to 2033 Figure 122: Eastern Europe Market Attractiveness by Disease Indication, 2023 to 2033 Figure 123: Eastern Europe Market Attractiveness by Animal Type, 2023 to 2033 Figure 124: Eastern Europe Market Attractiveness by Distribution Channel, 2023 to 2033 Figure 125: Eastern Europe Market Attractiveness by Country, 2023 to 2033 Figure 126: South Asia and Pacific Market Value (US$ Million) by Therapy Type, 2023 to 2033 Figure 127: South Asia and Pacific Market Value (US$ Million) by Disease Indication, 2023 to 2033 Figure 128: South Asia and Pacific Market Value (US$ Million) by Animal Type, 2023 to 2033 Figure 129: South Asia and Pacific Market Value (US$ Million) by Distribution Channel, 2023 to 2033 Figure 130: South Asia and Pacific Market Value (US$ Million) by Country, 2023 to 2033 Figure 131: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 132: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 133: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 134: South Asia and Pacific Market Value (US$ Million) Analysis by Therapy Type, 2018 to 2033 Figure 135: South Asia and Pacific Market Value Share (%) and BPS Analysis by Therapy Type, 2023 to 2033 Figure 136: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Therapy Type, 2023 to 2033 Figure 137: South Asia and Pacific Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033 Figure 138: South Asia and Pacific Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033 Figure 139: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033 Figure 140: South Asia and Pacific Market Value (US$ Million) Analysis by Animal Type, 2018 to 2033 Figure 141: South Asia and Pacific Market Value Share (%) and BPS Analysis by Animal Type, 2023 to 2033 Figure 142: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Animal Type, 2023 to 2033 Figure 143: South Asia and Pacific Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033 Figure 144: South Asia and Pacific Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033 Figure 145: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033 Figure 146: South Asia and Pacific Market Attractiveness by Therapy Type, 2023 to 2033 Figure 147: South Asia and Pacific Market Attractiveness by Disease Indication, 2023 to 2033 Figure 148: South Asia and Pacific Market Attractiveness by Animal Type, 2023 to 2033 Figure 149: South Asia and Pacific Market Attractiveness by Distribution Channel, 2023 to 2033 Figure 150: South Asia and Pacific Market Attractiveness by Country, 2023 to 2033 Figure 151: East Asia Market Value (US$ Million) by Therapy Type, 2023 to 2033 Figure 152: East Asia Market Value (US$ Million) by Disease Indication, 2023 to 2033 Figure 153: East Asia Market Value (US$ Million) by Animal Type, 2023 to 2033 Figure 154: East Asia Market Value (US$ Million) by Distribution Channel, 2023 to 2033 Figure 155: East Asia Market Value (US$ Million) by Country, 2023 to 2033 Figure 156: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 157: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 158: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 159: East Asia Market Value (US$ Million) Analysis by Therapy Type, 2018 to 2033 Figure 160: East Asia Market Value Share (%) and BPS Analysis by Therapy Type, 2023 to 2033 Figure 161: East Asia Market Y-o-Y Growth (%) Projections by Therapy Type, 2023 to 2033 Figure 162: East Asia Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033 Figure 163: East Asia Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033 Figure 164: East Asia Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033 Figure 165: East Asia Market Value (US$ Million) Analysis by Animal Type, 2018 to 2033 Figure 166: East Asia Market Value Share (%) and BPS Analysis by Animal Type, 2023 to 2033 Figure 167: East Asia Market Y-o-Y Growth (%) Projections by Animal Type, 2023 to 2033 Figure 168: East Asia Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033 Figure 169: East Asia Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033 Figure 170: East Asia Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033 Figure 171: East Asia Market Attractiveness by Therapy Type, 2023 to 2033 Figure 172: East Asia Market Attractiveness by Disease Indication, 2023 to 2033 Figure 173: East Asia Market Attractiveness by Animal Type, 2023 to 2033 Figure 174: East Asia Market Attractiveness by Distribution Channel, 2023 to 2033 Figure 175: East Asia Market Attractiveness by Country, 2023 to 2033 Figure 176: Middle East and Africa Market Value (US$ Million) by Therapy Type, 2023 to 2033 Figure 177: Middle East and Africa Market Value (US$ Million) by Disease Indication, 2023 to 2033 Figure 178: Middle East and Africa Market Value (US$ Million) by Animal Type, 2023 to 2033 Figure 179: Middle East and Africa Market Value (US$ Million) by Distribution Channel, 2023 to 2033 Figure 180: Middle East and Africa Market Value (US$ Million) by Country, 2023 to 2033 Figure 181: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 182: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 183: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 184: Middle East and Africa Market Value (US$ Million) Analysis by Therapy Type, 2018 to 2033 Figure 185: Middle East and Africa Market Value Share (%) and BPS Analysis by Therapy Type, 2023 to 2033 Figure 186: Middle East and Africa Market Y-o-Y Growth (%) Projections by Therapy Type, 2023 to 2033 Figure 187: Middle East and Africa Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033 Figure 188: Middle East and Africa Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033 Figure 189: Middle East and Africa Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033 Figure 190: Middle East and Africa Market Value (US$ Million) Analysis by Animal Type, 2018 to 2033 Figure 191: Middle East and Africa Market Value Share (%) and BPS Analysis by Animal Type, 2023 to 2033 Figure 192: Middle East and Africa Market Y-o-Y Growth (%) Projections by Animal Type, 2023 to 2033 Figure 193: Middle East and Africa Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033 Figure 194: Middle East and Africa Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033 Figure 195: Middle East and Africa Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033 Figure 196: Middle East and Africa Market Attractiveness by Therapy Type, 2023 to 2033 Figure 197: Middle East and Africa Market Attractiveness by Disease Indication, 2023 to 2033 Figure 198: Middle East and Africa Market Attractiveness by Animal Type, 2023 to 2033 Figure 199: Middle East and Africa Market Attractiveness by Distribution Channel, 2023 to 2033 Figure 200: Middle East and Africa Market Attractiveness by Country, 2023 to 2033
Recommendations
Explore Healthcare Insights
View Reports
